Last reviewed · How we verify

NCT06156631: DASH-ExMAMI

Uncontrolled Hypertension Management Among Jordanian Adults

Completed NA Last updated 22 October 2024
What this trial tests

NA trial testing DASH-ExMAMI in Hypertension in 126 participants. Completed in 7 October 2024.

Timeline
7 June 2024
Primary endpoint
5 September 2024
7 October 2024

Quick facts

Lead sponsorUniversiti Sains Malaysia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment126
Start date7 June 2024
Primary completion5 September 2024
Estimated completion7 October 2024
Sites4 locations across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Sains Malaysia — full company profile →

Who can join

Adults 18 to 65, any sex, with Hypertension or Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate a newly developed multimodal health intervention including dietary approach to stop hypertension (DASH) diet, exercise (Ex), and medication adherence (MA) using motivational interviewing (MI) counselling (DASH-Ex MAMI) for hypertensive Jordanian adults in primary care settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Universiti Sains Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06156631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing